Literature DB >> 12378647

Multivariate statistical analysis of clinicopathologic factors influencing survival of patients with bile duct carcinoma.

Ping He1, Jin-Sen Shi, Wu-Ke Chen, Zuo-Ren Wang, Hong Ren, Hua Li.   

Abstract

AIM: To evaluate the influence of various clinicopathologic factors on survival of patients with bile duct carcinoma after curative resection.
METHODS: A retrospective analysis was made for 86 cases of bile duct carcinoma treated from January 1981 to September 1995. Fifteen clinicopathologic factors possibly influencing survival were selected. Independent variables were first analyzed by univariate methods. Survival for variable was estimated by the method of Kaplan and Meier. The variables that were statistically significant by univariate analysis were included in a multivariate analysis, which were confirmed using the Cox stepwise proportion hazard model with the help of SPSS 10.0 for Windows software.
RESULTS: The overall cumulative survival rate was 72.6 % at 1 year, 32.4 % at 3 years, and 18.7 % at 5 years. The results of univariate analysis showed that the major significant prognostic factors influencing survival of these patients were histological type of lesion, lymph node metastasis, pancreatic invasion, duodenal invasion, perineural invasion, macroscopic vessel involvement, resected surgical margin and depth of cancer invasion (P=0.02, 0.02, 0.004, 0.005, 0.01, 0.43, 0.03 and 0.04). Age, sex, location of tumor, size of tumor, macroscopic type of lesions, hepatic metastasis, and hepatic invasion were not significantly associated with prognosis (P>0.05). Pancreatic invasion, perineural invasion and lymph node metastases were the three most important prognostic factors by multivariate analysis using the Cox proportional hazards model.
CONCLUSION: Pancreatic invasion, perineural invasion and lymph node metastases are the most important prognostic factors for bile duct carcinoma after curative resection.

Entities:  

Mesh:

Year:  2002        PMID: 12378647      PMCID: PMC4656592          DOI: 10.3748/wjg.v8.i5.943

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  23 in total

1.  Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience.

Authors:  M F Gerhards; T M van Gulik; L T de Wit; H Obertop; D J Gouma
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

2.  Results of resection for hilar cholangiocarcinoma with analysis of prognostic factors.

Authors:  R Havlik; E Sbisà; A Tullo; M D Kelly; R R Mitry; L R Jiao; M R Mansour; K Honda; N A Habib
Journal:  Hepatogastroenterology       Date:  2000 Jul-Aug

Review 3.  Recent advances in the surgical treatment of pancreatic cancer.

Authors:  A Shankar; R C Russell
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

4.  Pathomorphological and histological prognostic factors in curatively resected ductal adenocarcinoma of the pancreas.

Authors:  W Meyer; C Jurowich; M Reichel; B Steinhäuser; P H Wünsch; C Gebhardt
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  [Proximal bile duct cholangiocarcinomas].

Authors:  M C Blanchet; C Ducerf; L Benoit; J P Gérard; J Baulieux
Journal:  Ann Chir       Date:  2000-11

6.  Extrahepatic bile duct carcinoma: a western experience with 118 consecutive patients.

Authors:  G B Doglietto; S Alfieri; F Pacelli; M Mutignani; G Costamagna; C Carriero; A Di Giorgio; V Papa
Journal:  Hepatogastroenterology       Date:  2000 Mar-Apr

Review 7.  Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach.

Authors:  K D Lillemoe; J L Cameron
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

8.  Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.

Authors:  Y Nimura; J Kamiya; S Kondo; M Nagino; K Uesaka; K Oda; T Sano; H Yamamoto; N Hayakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

9.  Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection.

Authors:  L Bortolasi; L J Burgart; G G Tsiotos; E Luque-De León; M G Sarr
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

Review 10.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

View more
  15 in total

Review 1.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

2.  Intrapancreatic distal common bile duct carcinoma: Analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas.

Authors:  Raul S Gonzalez; Pelin Bagci; Olca Basturk; Michelle D Reid; Serdar Balci; Jessica H Knight; So Yeon Kong; Bahar Memis; Kee-Taek Jang; Nobuyuki Ohike; Takuma Tajiri; Sudeshna Bandyopadhyay; Alyssa M Krasinskas; Grace E Kim; Jeanette D Cheng; N Volkan Adsay
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

3.  Surgical strategy for bile duct cancer: Advances and current limitations.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Daijo Hashimoto
Journal:  World J Clin Oncol       Date:  2011-02-10

Review 4.  Mechanisms of cancer dissemination along nerves.

Authors:  Moran Amit; Shorook Na'ara; Ziv Gil
Journal:  Nat Rev Cancer       Date:  2016-05-06       Impact factor: 60.716

5.  Impact of tumor spread to the cystic duct on the prognosis of patients with gallbladder carcinoma.

Authors:  Takenari Nakata; Akira Kobayashi; Shiro Miwa; Junpei Soeda; Shinichi Miyagawa
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

Review 6.  Tumor progression: the neuronal input.

Authors:  Marco Arese; Federico Bussolino; Margherita Pergolizzi; Laura Bizzozero; Davide Pascal
Journal:  Ann Transl Med       Date:  2018-03

7.  Pancreatic and duodenal invasion in distal bile duct cancer: paradox in the tumor classification of the American Joint Committee on Cancer.

Authors:  Tomoki Ebata; Masato Nagino; Hideki Nishio; Tsuyoshi Igami; Yukihiro Yokoyama; Yuji Nimura
Journal:  World J Surg       Date:  2007-10       Impact factor: 3.352

8.  Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.

Authors:  Hee Joon Kim; Choong Young Kim; Young Hoe Hur; Yang Seok Koh; Jung Chul Kim; Hyun Jong Kim; Chol Kyoon Cho
Journal:  Surg Today       Date:  2014-02-18       Impact factor: 2.549

Review 9.  Resection for Klatskin tumors: technical complexities and results.

Authors:  Ivan Capobianco; Jens Rolinger; Silvio Nadalin
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18

10.  Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.

Authors:  Roman Kloeckner; Christian Ruckes; Kai Kronfeld; Marcus Alexander Wörns; Arndt Weinmann; Peter Robert Galle; Hauke Lang; Gerd Otto; Waltraud Eichhorn; Mathias Schreckenberger; Christoph Dueber; Michael Bernhard Pitton
Journal:  Trials       Date:  2014-08-06       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.